According to the Wall Street Journal, the Federal Drug Administration will bar Juul Labs from remaining on the market and could announce the decision as soon as Wednesday.

US-INDUSTRY-TOBACCO-HEALTH-TEENS

The man smokes from an electronic cigarette.

AFP via Getty Images

The FDA asked Juul and other e-cigarette companies to apply to keep their products on the market.

Last year, the agency put off a deadline to decide if Juul's tobacco-flavor products provide enough health benefits to warrant remaining on the market.

The company can either appeal the decision, challenge it in court or submit a modified application for the products.

Forbes did not get a response from the FDA.

PLAY Forbes Business Full Screen About Connatix At Least 280 People Dead After 6.1 Magnitude Earthquake Strikes Afghanistan Read More ‘Samrat Prithviraj’ Earns $8.4 Million In Two Weeks, ‘Bhool Bhulaiyaa 2’ Bags $23.3 Million In Four Weeks Read More Laver Cup Announces Vancouver, Berlin As Next Two Host Cities Read More Read More Ukraine National Soccer Team Return To Women’s World Cup Action In Poland Read More Billionaire Enrique Razon’s Prime Infra To Raise Up To $518 Million From Philippine IPO Read More 1/1 Skip Ad Continue watching after the ad Loading PodsVisit Advertiser websiteGO TO PAGE At Least 280 People Dead After 6.1 Magnitude Earthquake Strikes Afghanistan

Three years after it was blamed for causing a spike in the number of young people using e-cigs, Juul stopped selling certain flavors and stopped marketing to kids. The startup was accused of targeting youth and adolescents with marketing tactics that suggested the products were less harmful than traditional cigarettes. Two years ago, the FDA banned fruity products from being sold in the U.S., which led to the downfall of Juul. Reynolds American and NJOY were allowed by the agency to remain on the market. The reviews were part of a larger effort by the FDA to increase its regulation of tobacco products.

Big Number

It's more than $32 billion. When the tobacco giant reported in 2020 that it believed its stake in Juul was only worth $600 million, it marked down its valuation of the company. The plunge came as the FDA set its sights on tackling the youth epidemic and after the company faced a number of lawsuits.

The New York Times reported that Juul is fighting to keep its products on the US market.

The FDA wants to stop the sale of Juul e-Cigarettes in the United States.